🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How do we facilitate informed consent for approved #genetherapy + #celltherapy products? Providers should acknowledge limits & share what they know to help patients navigate expectations, says Dr. Jodi Wolff (Rejuvenate Bio). #PatientEducation bit.ly/3Gzq7Zo

‘We’re turning aging research into a therapeutic category’ Rejuvenate Bio CEO dan on why sourcing gene therapy targets from aging research may hold the key to treating many chronic diseases. george church #longevity #aging #genetherapy longevity.technology/news/were-turn…

Interviews of 2023: the longevity companies Six of our favourite interviews with companies operating at the cutting edge of longevity science. #biotech #innovation #2023 #longevity longevity.technology/news/interview…

Join our CEO dan at #JPM24 #BiotechShowcase24 on Tuesday Jan 9 for this #Cell and #Gene Therapy panel. 🧬🧬🧬 Lumanity Lexi Rovner 64x Bio JURA Bio, Inc. Elizabeth Wood 🧬🖥️🥼 Aegle Therapeutics Corp More info here: 👇👇👇 informaconnect.com/biotech-showca…

Rejuvenate Bio Announces Partnership with Leading Animal Health Company to Develop Gene Therapy for Canine Osteoarthritis dlvr.it/T2kmCW

Rejuvenate Bio makes progress on osteoarthritis gene therapy for dogs Gene therapy company inks strategic partnership with animal health firm to develop ‘one-dose’ injection treatment for canine #osteoarthritis. Rejuvenate Bio #longevity #doghealth longevity.technology/news/rejuvenat…

How long would you like to live? Or more importantly, how long would you like to feel healthy, energetic, and able to make the most of your life? This week, we interviewed Noah Davidsohn (Chief Scientific Officer and Co-founder at Rejuvenate Bio) – an innovator in epigenetics

Our new article reveals that gene therapy-mediated partial reprogramming extends lifespan and reverses age-related changes in aged mice, showcasing lifespan extension in wild-type animals through in vivo reprogramming. Noah Carolina Cano M Rejuvenate Bio liebertpub.com/doi/10.1089/ce…

New paper out from Rejuvenate Bio Congrats to everyone who contributed! Carolina Cano M Yuancheng (Ryan) Lu Louis Metzger, PhD liebertpub.com/doi/10.1089/ce… businesswire.com/news/home/2024…

Rejuvenate Bio shows epigenetic reprogramming extends #lifespan in normal mice New paper first to show that gene therapy-mediated partial #reprogramming extends lifespan and reverses age-related changes in aged wild mice. Rejuvenate Bio #longevity longevity.technology/news/rejuvenat…

Exciting developments from Wyss startup Rejuvenate Bio!

wired.me/science/health… thanks WIRED Middle East for sharing the work we are doing Rejuvenate Bio

We’re excited to present at ASGCT 2024 on our RJB-0402 gene therapy which targets key disease-mediating pathways in arrhythmogenic cardiomyopathy (ACM). 🧬🧬 Read the release: businesswire.com/news/home/2024…

BIO 2024: The CEO of Rejuvenate Bio on the company's liver directed gene therapy program targeting FGF21. #BIO2024 Full video: biotechtv.com/post/rejuvenat…

Rejuvenate Bio Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM) dlvr.it/T911bn

Excited to announce we received $4M in funding from California Institute for Regenerative Medicine to develop our gene therapy RJB-0402 for the treatment of desmoplakin gene variant arrhythmogenic cardiomyopathy. Read the release: businesswire.com/news/home/2024…

Rejuvenate Bio lands $4m grant to develop gene therapy with longevity potential CIRM funding will support the company through IND-enabling studies of FGF21-boosting gene therapy for genetic heart condition. #longevity #funding #genetherapy longevity.technology/news/rejuvenat…

Bioprocess International speaks with our CEO dan about the $4M California Institute for Regenerative Medicine grant: 🧬🧬 bioprocessintl.com/bioprocess-ins…

Our CEO dan was at LSX Leaders in Boston on the Commercialization Strategies for Biotechs and Early Planning panel. Thanks for joining us and see you at the next event! 🧬🧬